FDA Streamlines 510(k) Process, As Courts Reconsider It

Law360 (November 15, 2018, 12:39 PM EST) -- Change is in store for the Section 510(k) substantial equivalence approval process for Class II medical devices, both from the U.S. Food and Drug Administration and the courts. The FDA is working to streamline and expedite the Section 510(k) process, just as courts are giving more credence to the argument that Section 510(k) review and approval results in a finding of safety and effectiveness by the FDA — a trend which could have significant implications for punitive damages claims brought against manufacturers of Class II devices.

Changes to Section 510(k): The Quik Review Program Pilot

On Sept. 6, 2018, the FDA...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!